Semaglutide : What Side Effects You Need To Know

Common Side Effects of Semaglutide

In clinical trials, the most common side effects of semaglutide were gastrointestinal, such as nausea, diarrhea, and constipation. These side effects were generally mild to moderate and tended to diminish over time. In rare cases, semaglutide can cause pancreatitis or thyroid tumors, so it should be used with caution in individuals with a history of these conditions.

In addition, semaglutide can cause a decrease in appetite and a reduction in food intake, which can result in weight loss. While weight loss can be a desirable outcome for many individuals, it is important to monitor for potential negative consequences, such as malnutrition or inadequate nutrient intake.

Serious Side Effects of Semaglutide

In rare cases, semaglutide can cause serious side effects, such as pancreatitis or thyroid tumors. These side effects are more likely to occur in individuals with a history of pancreatitis or medullary thyroid carcinoma. It is important for individuals to inform their healthcare provider if they have a history of these conditions before starting semaglutide.

In addition, semaglutide can cause hypoglycemia (low blood sugar) when used in combination with other diabetes medications that can also lower blood sugar. Symptoms of hypoglycemia can include shakiness, dizziness, sweating, confusion, and difficulty concentrating. Individuals using semaglutide should monitor their blood sugar regularly and inform their healthcare provider if they experience symptoms of hypoglycemia.

Who Should Use Semaglutide?

Semaglutide is currently approved by the FDA for use in adults with a BMI of 27 or higher who have at least one weight-related health condition, such as high blood pressure or type 2 diabetes. It is intended to be used in conjunction with diet and exercise, and should only be prescribed by a healthcare provider who is familiar with its use.

You should speak to an expert about semaglutide use and if you encounter side effects using it.